Aurinia Pharmaceuticals Inc. (AUPH) Operating cash flow 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$135.7MFY2025 · since FY2018: -$51.6M → $135.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $135.7M | +205.6% |
| FY2024 | $44.4M | +232.7% |
| FY2023 | -$33.5M | +57.9% |
| FY2022 | -$79.5M | +49.6% |
| FY2021 | -$157.7M | -125.7% |
| FY2020 | -$69.9M | -9.9% |
| FY2019 | -$63.6M | -23.2% |
| FY2018 | -$51.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice